• Japan, Great Britain and Italy will develop a new fighter jet via BAE Systems, Leonardo and Mitsubishi Heavy Industries.
  • Mastercard launches a new $11 billion share buyback program and increases its quarterly dividend by 16%.
  • Telefonica does not intend to delist Telefonica Deutschland following its current takeover bid.
  • Apple has asked its component suppliers to source the batteries for the iPhone 16 from India.
  • Rio Tinto will spend around $6.2 billion on Simandou iron ore project.
  • Diageo seeks to divest the remainder of its beer portfolio, but would retain Guinness.
  • Merck KGaA announces the failure of a multiple sclerosis drug in phase III clinical trials.
  • Fresenius will not pay dividends or bonuses for 2023, because it has decided not to repay state aid to offset energy costs.
  • ASM International plans to expand its US site with a €300 million investment.
  • Nvidia develops new chips that comply with US export regulations.
  • Chinese EV manufacturer Nio to spin off its battery production unit.
  • JPMorgan Chase believes that the integration of First Republic Bank is proceeding according to plan.
  • UniCredit seeks a new presidential candidate by early 2024.
  • Hensoldt acquires ESG Elektroniksystem for €675m.
  • TUI expects further growth after doubling profits last year.
  • EQT sells its remaining stake in BHG Group.
  • Natura has reportedly explored the possibility of selling the Avon International cosmetics group, according to the FT.
  • A UK judge approves $737m Entain settlement in Turkish bribery investigation.
  • Audit of Xinjiang site reveals no signs of forced labor, announces Volkswagen.
  • Pierer Mobility lowers its forecasts for 2023 and refocuses its activities.
  • Airbnb appoints new CFO.
  • Members of actors' union SAG-AFTRA on Tuesday approved a three-year contract with major studios, officially ending six months of labor unrest.
  • British American Tobacco said on Wednesday that it would incur a loss of around $31.5 billion after its write-down of the value of certain US cigarette brands.
  • Johnson & Johnson announced on Tuesday that it had recently reached settlements with several civil parties accusing the talc produced by the group of causing cancer.
  • Airline profits are expected to stabilize in 2024, as confirmation of post-pandemic air travel growth is offset by high capital costs and capacity constraints, the International Air Transport Association (Iata) said.
  • Delta Air Lines on Wednesday reaffirmed its profit and revenue forecasts for 2023, with travel demand remaining stable.
  • Yext- The data management company falls 15.8% before the open, after lowering its FY 2024 sales to a range of $403.2 to $403.7 million, against a previously forecast range of $405 to $407 million.
  • Danaher- The medical tools supplier announced on Wednesday that it had completed the acquisition of Abcam for $5.7 billion, despite opposition from the target's founder.
  • Pharvaris - The drug developer is up around 45.6% ahead of the open after reporting that an experimental drug has met the targets of a mid-term study to treat and prevent attacks of hereditary angioedema.
  • Norway's largest private-sector union said on Wednesday that it could, from December 20, start blocking all exports of Tesla cars destined for the Swedish market.
  • Campbell Soup beat Wall Street expectations for quarterly earnings on Wednesday, as price increases offset a slowdown in demand.
  • Exxon Mobil raised its production forecast for 2024 to 3.8 million barrels per day. The company also said it would increase the pace of share buybacks to $20 billion a year from the closing of the Pioneer buyout to 2025.
  • US competition authorities will try again on Wednesday to prevent Microsoft from buying Activision Blizzard, even though the deal has already closed.
  • Novavax said on Tuesday that Health Canada had granted extended approval for its COVID-19 vaccine. The stock gained 3% before the opening.
  • Box - The software company fell by 12.4% before the opening, as the group forecast fourth-quarter sales of $262 to $264 million, below analysts' estimates of $265.8 million.